Cambrex Overview

  • Founded
  • 1981
Founded
  • Status
  • Private
  • Employees
  • 2,100
Employees
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 2
  • Investments
  • 10

Cambrex General Information

Description

Cambrex Corp is a biotechnology company focused on developing and commercializing new and generic therapeutics. The company primarily supplies its products and services worldwide to innovator and generic pharmaceutical companies. Cambrex's portfolio growth strategy has a particular focus on the later stages of the clinical trial process. It also works to secure long-term supply agreements to produce active pharmaceutical ingredients and intermediates for newly approved drug products. Additionally, Cambrex sometimes works with partners to co-develop portfolios of niche generic drug products in a finished dosage form.

Contact Information

Website
Formerly Known As
CasChem
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
  • One Meadowlands Plaza
  • 15th Floor
  • East Rutherford, NJ 07073
  • United States
+1 (201) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cambrex Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cambrex‘s full profile, request access.

Request a free trial

Cambrex Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Cambrex Corp is a biotechnology company focused on developing and commercializing new and generic therapeutics. The comp
Pharmaceuticals
East Rutherford, NJ
2,100 As of 2020
0.00 0000-00-00
000000000000

00000000

e velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident,
0000 000000000
Cork, Ireland
00 As of 0000
000.00
0000000000 0 000.00

00000000

dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur si
000000000000000
Brentford, United Kingdom
00000 As of 0000
00000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cambrex Competitors (32)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Solvotrin Therapeutics Venture Capital-Backed Cork, Ireland 00 000.00 0000000000 0 000.00
000000000000000 Corporation Brentford, United Kingdom 00000 00000000000
0000000000 0000000 Corporation Ingelheim am Rhein, Germany 00000
000000 000000 0000 Corporation Montreal, Canada 000
000000 00000000000 Corporation Tokyo, Japan 00000 00000000
You’re viewing 5 of 32 competitors. Get the full list »

Cambrex Executive Team (19)

Name Title Board Seat Contact Info
Thomas Loewald Chief Executive Officer
Troy Player President
Robert Green Executive Vice President & Co-Chief Financial Officer
Dorothy Donnelly-Brienza Executive Director, Chief Human Resources Officer and Senior Vice President
Brandon Fincher Senior Director, Corporate Strategy & Finance
You’re viewing 5 of 19 executive team members. Get the full list »

Cambrex Board Members (7)

Name Representing Role Since
00000 000000 Self Chairman 000 0000
You’re viewing 1 of 7 board members. Get the full list »

Cambrex Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cambrex Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cambrex‘s full profile, request access.

Request a free trial

Cambrex Acquisitions (10)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 02-Jan-2019 000000000000000000 00000 Drug Discovery 000000 00000 00
0000 0000000000000 12-Sep-2018 000000000000000000 00000 Drug Discovery 000000 00000 00
0000000 0000 00000 07-Oct-2016 000000000000000000 000.00 Biotechnology 000000 00000 00
0000000 000000 03-Nov-2010 000000000000000000 0000 Drug Discovery 000000 00000 00
IEP 23-Mar-2010 Merger/Acquisition 00.000 Specialty Chemicals
You’re viewing 5 of 10 acquisitions. Get the full list »

Cambrex Subsidiaries (4)

Company Name Industry Location Founded
Halo Pharmaceutical Canada Pharmaceuticals Mirabel, Canada 2018
0000 0000000000000 Drug Discovery Whippany, NJ 0000
0000000 000000 Drug Discovery Hyderabad, India 0000
0000000 0000 00000 Biotechnology High Point, NC 0000
To view Cambrex’s complete subsidiaries history, request access »

Cambrex Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000 (000000 0 30-Oct-2001 000000000000000000 Completed
  • 0000000
To view Cambrex’s complete exits history, request access »